GSMSX
Price
$34.39
Change
-$1.12 (-3.15%)
Updated
Dec 18 closing price
VIMAX
Price
$327.44
Change
-$11.29 (-3.33%)
Updated
Dec 18 closing price
Ad is loading...

GSMSX vs VIMAX

Header iconGSMSX vs VIMAX Comparison
Open Charts GSMSX vs VIMAXBanner chart's image
Goldman Sachs Mid Cap Value Svc
Price$34.39
Change-$1.12 (-3.15%)
VolumeN/A
CapitalizationN/A
Vanguard Mid Cap Index Admiral
Price$327.44
Change-$11.29 (-3.33%)
VolumeN/A
CapitalizationN/A
GSMSX vs VIMAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GSMSX vs. VIMAX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSMSX is a Sell and VIMAX is a Buy.

FUNDAMENTALS
Fundamentals
VIMAX has more cash in the bank: 190B vs. GSMSX (1.14B). VIMAX pays higher dividends than GSMSX: VIMAX (1.49) vs GSMSX (0.37). GSMSX was incepted earlier than VIMAX: GSMSX (27 years) vs VIMAX (23 years). GSMSX is a more actively managed with annual turnover of: 64.00 vs. VIMAX (13.00). GSMSX has a lower initial minimum investment than VIMAX: GSMSX (0) vs VIMAX (3000). VIMAX annual gain was more profitable for investors over the last year : 18.84 vs. GSMSX (10.22). VIMAX return over 5 years is better than : 55.75 vs. GSMSX (10.33).
GSMSXVIMAXGSMSX / VIMAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence27 years23 years-
Gain YTD8.75717.82949%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.14B190B1%
Annual Yield % from dividends0.371.4925%
Returns for 1 year10.2218.8454%
Returns for 3 years-4.5311.37-40%
Returns for 5 years10.3355.7519%
Returns for 10 years-7.76125.53-6%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OUST11.001.62
+17.27%
Ouster
MRBK15.16-0.23
-1.49%
Meridian Corp
CHE524.98-15.14
-2.80%
Chemed Corp
PPBI26.57-0.94
-3.42%
Pacific Premier Bancorp
QLGN4.23-0.16
-3.64%
Qualigen Therapeutics Inc